Freenome vs IMU Biosciences
Freenome vs IMU Biosciences, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Freenome is on 59/100 and IMU Biosciences on 47/100.
Where each one leads
Freenome
- our overall score: 59/100 against 47/100
- domain rating: 57/100 against 23/100
- funding raised: $570M against $53.0M
IMU Biosciences
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Freenome | IMU Biosciences |
|---|---|---|
| What it is | Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology. | Decoding the immune system to pioneer a paradigm shift in disease diagnosis and treatment. |
| Category | Biotechnology, Healthcare, Artificial Intelligence, Biotech | Biotechnology, Artificial Intelligence, HealthTech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Platform |
| Founded | 2014 | Not published |
| Headquarters | South San Francisco, USA | London, United Kingdom |
| Status | Active | Active |
Size, funding and growth
| Measure | Freenome | IMU Biosciences |
|---|---|---|
| Employees | 402 | Not published |
| Total funding | $570M | $53.0M |
| Latest round | Series D | Series A |
| Valuation | $1.1B | Not published |
| LinkedIn followers | 46,860 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Freenome | IMU Biosciences |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 59/100 | 47/100 |
| Traction | 60/100 | 39/100 |
| Search visibility | 31/100 | 4/100 |
| Quality | 78/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (46/100) | D (42/100) |
| Domain ratingLink authority, 0-100 | 57/100 | 23/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Freenome | IMU Biosciences |
|---|---|---|
| CMS | WordPress | Framer |
| Frameworks | Jquery | Not detected |
| Analytics | Google Tag Manager | Not detected |
| Support stack | HubSpot | Not detected |
Freenome vs IMU Biosciences: common questions
Which is better, Freenome or IMU Biosciences?
On our 0-100 score Freenome rates higher (59/100 against 47/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do Freenome and IMU Biosciences compare on the numbers?
Freenome leads on our overall score (59/100 against 47/100), domain rating (57/100 against 23/100), funding raised ($570M against $53.0M).
Read the full Freenome review and pricing or the IMU Biosciences review and pricing. You can also browse other Freenome alternatives we track.